AHA Updates Treatment Guidelines for Atrial Fibrillation
|
By HospiMedica International staff writers Posted on 04 Feb 2019 |
|
Image: New research shows NOACs are preferred over warfarin as an anticoagulant in AF (Photo courtesy of 123RF).
The American Heart Association (AHA; Dallas, TX, USA), American College of Cardiology (ACC; Washington, DC, USA), and the Heart Rhythm Society (HRS; Washington, DC, USA) now recommend the use of non-vitamin K oral anticoagulants (NOACs) over traditional warfarin to prevent stroke in people with atrial fibrillation (AF).
The recommendations are the result of a focused update to the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. The new guideline also suggests that NOACs could even be used in people at a lower risk of stroke than previously thought, with emerging research suggesting the benefit of NOACs in stroke reduction risk outweighs the risk of taking them. The recommendation was simultaneously published on January 29, 2019, in Circulation, the Journal of the American College of Cardiology (JACC), and HeartRhythm.
“Patients with atrial fibrillation are at increased risk of stroke, which can be devastating. A goal of treating AF patients is to make blood less likely to form clots, which reduces the risk of stroke,” said Craig T. January, MD, PhD, co-chair of the updated guideline committee. “NOACs may be safer for patients because there is less risk of bleeding, and they may also be more effective at preventing blood clots than warfarin. AF patients should talk to their healthcare provider about any concerns they have about their prescribed medications and whether or not losing weight would benefit their health.”
Until the introduction of NOACs, warfarin had been one of the only treatment options for long-term anticoagulation of patients with AF, venous thromboembolism (VTE), or other conditions that require chronic anticoagulation. The major benefit of the NOAC anticoagulants is that they do not require strict and frequent laboratory monitoring, dosing adjustments, or dietary restrictions, and incur fewer drug interactions than warfarin. NOACs include dabigatran, rivaroxaban, apixaban, and edoxaban.
Related Links:
American Heart Association
American College of Cardiology
Heart Rhythm Society
The recommendations are the result of a focused update to the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. The new guideline also suggests that NOACs could even be used in people at a lower risk of stroke than previously thought, with emerging research suggesting the benefit of NOACs in stroke reduction risk outweighs the risk of taking them. The recommendation was simultaneously published on January 29, 2019, in Circulation, the Journal of the American College of Cardiology (JACC), and HeartRhythm.
“Patients with atrial fibrillation are at increased risk of stroke, which can be devastating. A goal of treating AF patients is to make blood less likely to form clots, which reduces the risk of stroke,” said Craig T. January, MD, PhD, co-chair of the updated guideline committee. “NOACs may be safer for patients because there is less risk of bleeding, and they may also be more effective at preventing blood clots than warfarin. AF patients should talk to their healthcare provider about any concerns they have about their prescribed medications and whether or not losing weight would benefit their health.”
Until the introduction of NOACs, warfarin had been one of the only treatment options for long-term anticoagulation of patients with AF, venous thromboembolism (VTE), or other conditions that require chronic anticoagulation. The major benefit of the NOAC anticoagulants is that they do not require strict and frequent laboratory monitoring, dosing adjustments, or dietary restrictions, and incur fewer drug interactions than warfarin. NOACs include dabigatran, rivaroxaban, apixaban, and edoxaban.
Related Links:
American Heart Association
American College of Cardiology
Heart Rhythm Society
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Immobilization System
Cranial 4Pi Immobilization
Multi-Chamber Washer-Disinfector
WD 390
Latest Critical Care News
- Multi-Night Home Monitoring Reduces Sleep Apnea Misdiagnosis
- AI-Guided Outreach System Improves Colorectal Cancer Screening
- FDA Breakthrough Device Targets Brain Hemorrhage Complications
- RFA Device Gains FDA Clearance for Minimally Invasive Thyroid Nodule Ablation
- ECG-Based Screening Framework Aims to Standardize Cardiac Evaluation in Military Personnel
- Inhaled Analgesic Matches Morphine for Prehospital Trauma Pain
- FDA Clears Tongue-Applied Neuromodulation System for Stroke Gait Rehabilitation
- Eye Test May Predict Return of Consciousness After Severe Brain Injury
- Medical Drone Program Improves Blood Access and Patient Survival
- AI System Enables Real-Time Sepsis Quality Assessment and Improves Adherence
- AI Detects Hidden ECG Marker of Sudden Cardiac Death
- FDA-Cleared AI Wearable Monitor Detects Opioid-Related Respiratory Risk in Hospitals
- Mitral Valve Repair Device Receives EU Approval for Functional Regurgitation
- AI Risk Score Reveals Hidden Hypertension-Related Organ Damage
- AI Tool Predicts Bronchopulmonary Dysplasia Risk in Preterm Infants
- Optical Brain Monitoring Predicts Neurodevelopmental Outcomes in Preterm Infants
Channels
Artificial Intelligence
view channel
AI Tool Predicts Chronic Kidney Disease Risk in Diabetes
Chronic kidney disease is a common and serious complication of type 2 diabetes and often progresses without obvious early symptoms, increasing morbidity and straining health systems. Many risk models were... Read more
AI Trends Report Guides Responsible, Effective Healthcare Deployment
Hospitals are under growing pressure to adopt artificial intelligence tools that improve safety, efficiency, and continuity of care without compromising quality. At the same time, clinicians need clearer... Read more
Surgical Techniques
view channel
Novel Microparticles Break Down Biofilms and Boost Antibiotic Activity
Biofilms are dense matrices of bacteria and proteins that shield microbes from disinfectants and drugs. They complicate wound care and the reprocessing of surgical instruments because standard agents often... Read more
Nerve Block Technique Reduces Opioid Use After Cardiac Surgery
Opioid exposure after open-heart surgery is associated with delirium, nausea, and other complications, and may contribute to longer-term dependence. Because cardiac procedures often still require high... Read more
Patient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Health IT
view channel
Digital Heart Model Supports Targeted Ablation in Atrial Fibrillation
Atrial fibrillation is an erratic, quivering heartbeat and a leading cause of stroke. Catheter ablation is widely used to interrupt arrhythmogenic tissue, yet many patients—especially with persistent ... Read more
AI Framework Helps Clinicians Create Trustworthy Risk Prediction Tools
Artificial intelligence (AI) is increasingly used to estimate risks for conditions such as sepsis, heart disease, and cancer, yet many models remain difficult for clinicians to interpret or trust.... Read more
Point of Care
view channel
New Brain Ultrasound Platform Enables Bedside Postoperative Imaging
Transporting postoperative patients for CT or MRI can create operational burdens, delays, and disruptions in care. Bedside visualization may help reduce transport demands, lower radiation exposure, and... Read more
Handheld Ultrasound Expands Point-of-Care Imaging Access in Brazil
Rapid access to diagnostic imaging is essential across hospitals, emergency departments, clinics, and municipal health systems, but large markets still face uneven availability, particularly in rural regions.... Read more
Business
view channel
Danaher Completes Acquisition of Masimo to Expand Patient Monitoring Capabilities
Danaher Corporation (Washington, DC, USA) has completed its acquisition of Masimo Corporation (Irvine, CA, USA), a specialty diagnostics provider known for pulse oximetry and advanced patient monitoring... Read more
